NO20031071L - Fremgangsmåte for å inhibere nedgang i transdermal medikamentgjennomströmming ved inhibisjon ved lukking av reaksjonsveien - Google Patents

Fremgangsmåte for å inhibere nedgang i transdermal medikamentgjennomströmming ved inhibisjon ved lukking av reaksjonsveien

Info

Publication number
NO20031071L
NO20031071L NO20031071A NO20031071A NO20031071L NO 20031071 L NO20031071 L NO 20031071L NO 20031071 A NO20031071 A NO 20031071A NO 20031071 A NO20031071 A NO 20031071A NO 20031071 L NO20031071 L NO 20031071L
Authority
NO
Norway
Prior art keywords
agent
inhibiting
inhibition
closing
decrease
Prior art date
Application number
NO20031071A
Other languages
English (en)
Norwegian (no)
Other versions
NO20031071D0 (no
Inventor
Weiqi Lin
Michel J N Cormier
Peter E Daddona
Juanita A Johnson
James A Matriano
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of NO20031071D0 publication Critical patent/NO20031071D0/no
Publication of NO20031071L publication Critical patent/NO20031071L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Surgical Instruments (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
NO20031071A 2000-09-08 2003-03-07 Fremgangsmåte for å inhibere nedgang i transdermal medikamentgjennomströmming ved inhibisjon ved lukking av reaksjonsveien NO20031071L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23116000P 2000-09-08 2000-09-08
PCT/US2001/027551 WO2002019985A2 (fr) 2000-09-08 2001-09-06 Procedes permettant d'enrayer une diminution de l'ecoulement d'un medicament par voie transdermique fondes sur l'inhibition de l'obturation du passage

Publications (2)

Publication Number Publication Date
NO20031071D0 NO20031071D0 (no) 2003-03-07
NO20031071L true NO20031071L (no) 2003-05-06

Family

ID=22867983

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031071A NO20031071L (no) 2000-09-08 2003-03-07 Fremgangsmåte for å inhibere nedgang i transdermal medikamentgjennomströmming ved inhibisjon ved lukking av reaksjonsveien

Country Status (24)

Country Link
US (1) US7438926B2 (fr)
EP (1) EP1335711B1 (fr)
JP (2) JP5507030B2 (fr)
KR (1) KR100764699B1 (fr)
CN (1) CN100421653C (fr)
AT (1) ATE367805T1 (fr)
AU (2) AU8877401A (fr)
BR (1) BR0113749A (fr)
CA (1) CA2422200A1 (fr)
CZ (1) CZ2003687A3 (fr)
DE (1) DE60129585T2 (fr)
DK (1) DK1335711T3 (fr)
EE (1) EE200300095A (fr)
ES (1) ES2290166T3 (fr)
IL (1) IL154811A0 (fr)
MA (1) MA25958A1 (fr)
MX (1) MXPA03002122A (fr)
NO (1) NO20031071L (fr)
NZ (1) NZ524646A (fr)
PL (1) PL365603A1 (fr)
PT (1) PT1335711E (fr)
RU (1) RU2272618C2 (fr)
WO (1) WO2002019985A2 (fr)
ZA (1) ZA200302700B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2422200A1 (fr) * 2000-09-08 2002-03-14 Alza Corporation Procedes permettant d'enrayer une diminution de l'ecoulement d'un medicament par voie transdermique fondes sur l'inhibition de l'obturation du passage
IL155583A0 (en) * 2000-10-26 2003-11-23 Alza Corp Transdermal drug delivery devices having coated microprotrusions
US6908453B2 (en) * 2002-01-15 2005-06-21 3M Innovative Properties Company Microneedle devices and methods of manufacture
CN1842320B (zh) * 2003-06-30 2013-06-19 阿尔扎公司 含有不挥发性平衡离子的用于经涂覆的微突出物的制剂
UY28398A1 (es) * 2003-07-02 2004-11-08 Alza Corp Método y parche de inmunización por disposición de microproyección
JP2007503268A (ja) 2003-08-25 2007-02-22 スリーエム イノベイティブ プロパティズ カンパニー 免疫応答修飾化合物の送達
CN101415443A (zh) * 2003-10-23 2009-04-22 阿尔扎公司 涂覆微喷射体的稳定dna组合物
AU2004285484A1 (en) * 2003-10-24 2005-05-12 Alza Corporation Pretreatment method and system for enhancing transdermal drug delivery
WO2005051456A2 (fr) * 2003-11-13 2005-06-09 Alza Corporation Composition et appareil d'administration transdermique
KR20060135931A (ko) 2004-04-01 2006-12-29 알자 코포레이션 인플루엔자 백신의 경피전달 장치 및 방법
US20050226922A1 (en) * 2004-04-13 2005-10-13 Mahmoud Ameri Apparatus and method for transdermal delivery of fentanyl-based agents
EP1735469A2 (fr) * 2004-04-13 2006-12-27 ALZA Corporation Appareil et procede d'administration transdermique de multiples vaccins
MX2007001667A (es) * 2004-08-11 2007-10-02 Johnson & Johnson Aparato y metodo para el suministro transdermico de peptidos natriureticos.
CA2588080C (fr) * 2004-11-18 2013-01-08 3M Innovative Properties Company Procede de masquage pour le revetement d'un jeu de micro-aiguilles
CN101076409B (zh) 2004-11-18 2011-11-23 3M创新有限公司 接触涂敷微针阵列的方法
US8057842B2 (en) 2004-11-18 2011-11-15 3M Innovative Properties Company Method of contact coating a microneedle array
EP1853231A2 (fr) * 2005-02-16 2007-11-14 Alza Corporation Dispositif et procede d'administration transdermique d'agents a base d'epoetine s
US20060253078A1 (en) * 2005-04-25 2006-11-09 Wu Jeffrey M Method of treating skin disorders with stratum corneum piercing device
US20070270738A1 (en) * 2005-04-25 2007-11-22 Wu Jeffrey M Method of treating ACNE with stratum corneum piercing patch
WO2007002523A2 (fr) 2005-06-24 2007-01-04 3M Innovative Properties Company Timbre repliable et son procede d'application
US20070078414A1 (en) * 2005-08-05 2007-04-05 Mcallister Devin V Methods and devices for delivering agents across biological barriers
EP1948139A4 (fr) * 2005-11-18 2012-04-04 3M Innovative Properties Co Compositions pouvant être revêtues, revêtements dérivés de celles-ci et micro-réseaux comprenant de tels revêtements
EP2018835B1 (fr) * 2007-07-09 2014-03-05 Augustinus Bader Pavé sortant d'agent actif
US8617487B2 (en) 2009-03-25 2013-12-31 Venture Lending & Leasing Vi, Inc. Saliva sample collection systems
JPWO2011010456A1 (ja) * 2009-07-24 2012-12-27 株式会社ネクスト２１ ＮＳＡＩＤｓ含有外用剤及び当該外用剤の製造方法
EP2818159A1 (fr) 2013-06-25 2014-12-31 LTS LOHMANN Therapie-Systeme AG Dispositif doté d'un système thérapeutique transdermique, d'une aide au positionnement et d'une aide à la pénétration
US9987361B1 (en) * 2014-12-29 2018-06-05 Noven Pharmaceuticals, Inc. Compositions and method for sustained drug delivery by active transdermal technology
DE102017126501A1 (de) 2017-11-10 2019-05-16 Lts Lohmann Therapie-Systeme Ag Mikronadelsystem zur Applikation eines Hepatitis-Impfstoffes
US20190231925A1 (en) * 2018-01-31 2019-08-01 Changchun Ja Biotech. Co., Ltd. Heparin sodium supported hydrogel sustained-release paster

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE25637E (en) 1964-09-08 Means for vaccinating
US3964482A (en) 1971-05-17 1976-06-22 Alza Corporation Drug delivery device
BE795384A (fr) 1972-02-14 1973-08-13 Ici Ltd Pansements
EP0429842B1 (fr) * 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Dispositif d'administration transcutanée de médicaments à base de protéine ou de peptide
US5279544A (en) 1990-12-13 1994-01-18 Sil Medics Ltd. Transdermal or interdermal drug delivery devices
IL109037A (en) * 1993-03-19 1999-01-26 Cellegy Pharma Inc Preparations for causing phase separation of lipid layers and preparation of the above preparations
US5458140A (en) 1993-11-15 1995-10-17 Non-Invasive Monitoring Company (Nimco) Enhancement of transdermal monitoring applications with ultrasound and chemical enhancers
US5885211A (en) 1993-11-15 1999-03-23 Spectrix, Inc. Microporation of human skin for monitoring the concentration of an analyte
JPH10510175A (ja) * 1994-12-09 1998-10-06 ノバルティス アクチェンゲゼルシャフト 経皮システム
WO1996037256A1 (fr) 1995-05-22 1996-11-28 Silicon Microdevices, Inc. Timbre micromecanique pour ameliorer l'administration de composes a travers la peau
AU5740496A (en) 1995-05-22 1996-12-11 General Hospital Corporation, The Micromechanical device and method for enhancing delivery of compounds through the skin
DE19525607A1 (de) 1995-07-14 1997-01-16 Boehringer Ingelheim Kg Transcorneales Arzneimittelfreigabesystem
US5902603A (en) * 1995-09-14 1999-05-11 Cygnus, Inc. Polyurethane hydrogel drug reservoirs for use in transdermal drug delivery systems, and associated methods of manufacture and use
DE19541260A1 (de) * 1995-11-06 1997-05-07 Lohmann Therapie Syst Lts Therapeutische Zubereitung zur transdermalen Applikation von Wirkstoffen durch die Haut
ES2195151T3 (es) 1996-06-18 2003-12-01 Alza Corp Dispositivo de mejora de aporte o de muestreo de agentes transdermicos.
US6183434B1 (en) 1996-07-03 2001-02-06 Spectrx, Inc. Multiple mechanical microporation of skin or mucosa
ATE231015T1 (de) 1996-09-17 2003-02-15 Deka Products Lp System zur medikamentenabgabe durch transport
CN1133472C (zh) 1996-12-20 2004-01-07 阿尔萨公司 增加经皮样剂流量的装置
DE19654391A1 (de) 1996-12-27 1998-07-02 Basf Ag Katalysator zur selektiven Herstellung von Propylen aus Propan
DK1314400T3 (da) * 1996-12-31 2007-10-15 Altea Therapeutics Corp Mikroporering af væv til levering af bioaktive midler
US6918901B1 (en) * 1997-12-10 2005-07-19 Felix Theeuwes Device and method for enhancing transdermal agent flux
ATE221400T1 (de) * 1997-12-11 2002-08-15 Alza Corp Vorrichtung zur erhöhung des transdermalen wirkstoffeflusses
EP1037687B8 (fr) 1997-12-11 2008-10-22 Alza Corporation Dispositif renfor ant le flux d'agents transdermiques
DK1037686T3 (da) * 1997-12-11 2006-01-02 Alza Corp Apparat til forögelse af transdermal gennemströmning af midler
US6022316A (en) 1998-03-06 2000-02-08 Spectrx, Inc. Apparatus and method for electroporation of microporated tissue for enhancing flux rates for monitoring and delivery applications
CA2330207C (fr) 1998-06-10 2005-08-30 Georgia Tech Research Corporation Dispositifs a microaiguilles et procedes de fabrication et d'utilisation correspondants
CA2372919A1 (fr) * 1999-05-17 2000-11-23 Kevin S. Machitto Liberation controlee a distance et locale de composes pharmaceutiques faisant appel a l'energie electromagnetique
AU5461300A (en) * 1999-06-04 2000-12-28 Georgia Tech Research Corporation Devices and methods for enhanced microneedle penetration of biological barriers
CA2393537C (fr) * 1999-12-10 2009-02-03 Alza Corporation Dispositif de traitement cutane pour administration transdermique prolongee d'un medicament
ES2253278T3 (es) * 1999-12-10 2006-06-01 Alza Corporation Dispositivo y procedimiento para mejorar la perforacion cutanea con microprotuberancias.
CA2422200A1 (fr) * 2000-09-08 2002-03-14 Alza Corporation Procedes permettant d'enrayer une diminution de l'ecoulement d'un medicament par voie transdermique fondes sur l'inhibition de l'obturation du passage
IL155583A0 (en) * 2000-10-26 2003-11-23 Alza Corp Transdermal drug delivery devices having coated microprotrusions
AU2003275301A1 (en) * 2002-09-30 2004-04-23 Alza Corporation Drug delivery device having coated microprojections incorporating vasoconstrictors

Also Published As

Publication number Publication date
JP2004508319A (ja) 2004-03-18
KR20030074595A (ko) 2003-09-19
CA2422200A1 (fr) 2002-03-14
EE200300095A (et) 2005-02-15
BR0113749A (pt) 2004-06-22
ES2290166T3 (es) 2008-02-16
DK1335711T3 (da) 2007-11-26
IL154811A0 (en) 2003-10-31
MA25958A1 (fr) 2003-12-31
MXPA03002122A (es) 2004-09-10
PL365603A1 (en) 2005-01-10
CZ2003687A3 (cs) 2004-01-14
JP5507030B2 (ja) 2014-05-28
PT1335711E (pt) 2007-09-05
CN100421653C (zh) 2008-10-01
US20020102292A1 (en) 2002-08-01
DE60129585T2 (de) 2008-04-17
DE60129585D1 (de) 2007-09-06
JP2013256500A (ja) 2013-12-26
CN1473037A (zh) 2004-02-04
NZ524646A (en) 2004-10-29
WO2002019985A2 (fr) 2002-03-14
KR100764699B1 (ko) 2007-10-08
AU2001288774B2 (en) 2006-06-29
US7438926B2 (en) 2008-10-21
EP1335711B1 (fr) 2007-07-25
WO2002019985A3 (fr) 2002-09-06
RU2272618C2 (ru) 2006-03-27
ATE367805T1 (de) 2007-08-15
AU8877401A (en) 2002-03-22
EP1335711A2 (fr) 2003-08-20
ZA200302700B (en) 2004-08-13
NO20031071D0 (no) 2003-03-07

Similar Documents

Publication Publication Date Title
NO20031071L (no) Fremgangsmåte for å inhibere nedgang i transdermal medikamentgjennomströmming ved inhibisjon ved lukking av reaksjonsveien
WO2003032914A3 (fr) Procedes de traitement de la consommation abusive de substances psychoactives a l'aide d'inhibiteurs de la cholinesterase
WO2005018677A3 (fr) Utilisation d'un melange d'un inhibiteur de la kinase du recepteur de facteur de croissance epidermique et d'agents cytotoxiques dans le traitement et l'inhibition de cancer
WO2004006906A3 (fr) Methodes de traitement de neoplasmes
WO2009129509A3 (fr) Procédés et compositions pour traiter la douleur postopératoire comportant un anesthésique local
PL1624878T3 (pl) Zastosowanie kompozycji zawierającej estrogenowy składnik w celu leczenia i zapobiegania bólowi mięśniowo-szkieletowemu
WO2006047392A3 (fr) Synergie entre nicotine et opioides a des fins d'analgesie
WO2007149782A3 (fr) Inhibiteurs séléctifs pour les transférases
WO2005044194A3 (fr) Traitement ou prevention de la neoplasie a l'aide d'un inhibiteur de la proteine hsp90
WO2007123511A3 (fr) Schémas posologiques pour le traitement du cancer
WO2003092606A3 (fr) Inhibiteurs de cholinesterase pour prevenir les blessures causees par des produits chimiques
WO2001087343A3 (fr) Polytherapie faisant appel a un inhibiteur selectif de cox-2 et a un inhibiteur de la thromboxane ainsi que des compositions contenant ceux-ci
WO2002096351A3 (fr) Opioides a action ultrabreve pour application transdermique
WO2005037347A3 (fr) Traitement d'une tendinopathie due au surmenage, au moyen d'agents generateurs d'oxyde nitrique administres par voie transdermique
DE60213116D1 (de) Verwendung von carbinolen zur behandlung von neuropathischer funktionsstörung
HUP9801022A2 (hu) Eljárás aldóz reduktáz inhibítor alkalmazása diabetikus szívizom-betegség megelőzésére vagy megfordítására
WO2004007676A3 (fr) Therapie combinee servant a traiter des tumeurs
WO2000023062A3 (fr) Solution et methode d'irrigation destinees a l'inhibition d'une douleur et d'une inflammation
HK1122504A1 (en) Use of preparation of drugs for treatment and prevention of benign pigmented moles(naevi) using artemisinine and the derivatives thereof
GEP201606538B (en) Preoperative treatment of post operative pain
WO2002085292A3 (fr) Procede ameliore de traitement de manifestations aberrantes du tissu fibreux avec des preparations a base d'agent bloquant topique des canaux de calcium et composition amelioree utilisee dans ce traitement et son procede de fabrication ameliore
WO2004069029A3 (fr) Prevention des adherences chirurgicales a l'aide d'inhibiteurs selectifs du cox-2
WO2004028448A3 (fr) Procede d'attenuation de la douleur par inhibition de la synthese des neurotransmetteurs
NO20070774L (no) Sammensetninger for behandling av inflammasjon og smerte ved anvendelse av en kombinasjon av en COX-2- selektiv inhibitor og en LTB4 reseptorantagonist
SG150552A1 (en) Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor (tfpi)

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application